Perceptive Advisors - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$48,132,000
+51.1%
900,0000.0%0.78%
-6.0%
Q1 2020$31,860,000
-25.9%
900,0000.0%0.83%
-2.8%
Q4 2019$42,975,000
+30596.4%
900,000
+350.0%
0.85%
+21250.0%
Q1 2019$140,000
-99.3%
200,000
-20.0%
0.00%
-99.3%
Q1 2018$20,445,000250,0000.57%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders